BeiGene Ltd. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (31)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: Keymed/Lepu Sign $1.2 Billion Deal Out-Licensing Claudin 18.2 ADC To AstraZeneca
Article By: ChinaBio® Today
Saturday, February 25, 2023 3:20 PM EDT
Keymed Bio and Lepu Biopharma out-licensed global rights for their antibody drug conjugate to AstraZeneca in a deal that includes $63 million upfront. Meanwhile, the $937 million agreement between InnoCare and Biogen for an MS drug has been unwound.
In this article: AZN Also: NVS, BIIB, BGNE, KNTE
Read
Five Best And Worst Performing Healthcare Stocks In January 2023
Article By: ValueWalk
Sunday, February 5, 2023 1:40 PM EDT
After a sub-par performance in 2021, healthcare stocks outperformed the S&P 500 in 2022. As well, 2023 is expected to be another promising year for the sector. Let’s take a look at the five best and worst performing healthcare stocks in January 2023.
In this article: BAX, CNC, PFE, ALGN, IDXX, NBIX, EXAS, ABBV, BGNE, GEHC
Read
Five Best And Worst Performing Healthcare Stocks In December 2022
Article By: ValueWalk
Sunday, January 22, 2023 1:40 PM EDT
Multiple factors are expected to help the healthcare industry overcome inflationary pressures. If you are looking to invest in this sector, then to help you select, here are the five best and worst performing healthcare stocks in December 2022.
In this article: BAX, BMY, TFX, UHS, ALGN, ALNY, RPRX, VEEV, WBA, BGNE
Read
These Were The Five Best And Worst Performing Large-Cap Stocks In Q4 2022
Article By: ValueWalk
Friday, January 6, 2023 3:00 PM EDT
The year 2022 proved to be the worst calendar year for the S&P 500 since 2008. The benchmark index dropped more than 5% in December and almost 20% for the full year. Let’s take a look at the five best and worst performing large-cap stocks in Q4 2022.
In this article: BA, HAL, UHS, SIVBQ, BURL, BGNE, ZS, CRWD, LCID, RIVN
Read
Week In Review: Boston Scientific Pays $523 Million For Majority Stake In Beijing Acotec Scientific
Article By: ChinaBio® Today
Saturday, December 17, 2022 1:00 PM EDT
Boston Scientific will pay $523 million for a 65% stake in Acotec Scientific, a Beijing medical device company. Boston Scientific said the acquisition will build up its presence in China, and it will also bring Acotec’s products to western markets.
In this article: BSX Also: PRE, IMGN, BGNE, IVBXF
Read
All Posts

Latest Tweets for $BGNE

No tweets yet!

PARTNER HEADLINES

$BGNE

Comments Status Updates
The World Has Turned Sunny
Marcy Brown • 11/10/2020 2:19:18 AM

I don't really understand why $BGNE was downrated. The news was positive.

1 to 1 of 1 comments